Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04779606

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

A Phase I/II, Randomized, Placebo-controlled, Double-masked, Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Sponsor: Sintetica SA

Conditions Healthy Subjects

Interventions Ocular gel

Updated 6 times since 2021 Last updated: Aug 18, 2021 Started: Jun 16, 2020 Primary completion: Oct 13, 2020 Completion: Oct 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Healthy Subjects and is currently completed. Sintetica SA leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
Oct 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Apr 2021 — Oct 2021 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sintetica SA

Data source: Sintetica SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arzo, Switzerland